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Abstract: 
 
Background: Schizotypal traits are expressions of underlying vulnerability to psychotic 
disorders which have a potential impact on mental health status, neurocognition, quality of life, 
and daily functioning. To date, little research has examined epidemiologic landscape of 
schizotypal traits at the cross-national level. Our aim was to study the expression of schizotypal 
traits by sex, age, and country in a combined sample gathered from 12 countries. Methods: A 
total of 27,001 participants completed the Schizotypal Personality Questionnaire (SPQ). The 
mean age of participants was 22.12 (SD = 6.28); 37.5% (n = 10,126) were males. Results: 
Schizotypal traits varied according to sex, age, and country. Females scored higher than males in 
the positive dimension, whereas males scored higher in the disorganization dimension. By age, a 
significant decrease in the positive schizotypal traits was observed. Epidemiological expression 
of schizotypal traits varied by country. Moreover, several interactions by sex, age, and country 
were found. Conclusions: This pattern is similar to those found in patients with psychosis and 
psychotic-like experiences. These findings provide new insights and the opportunity to explore 
the phenotypic expression of schizotypal traits at cross-national level. 
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Article: 
 
1. Introduction 
 
Schizotypal traits are often viewed as phenotypic indicators of liability for schizophrenia-
spectrum disorders (Barrantes-Vidal et al., 2015; Fonseca Pedrero and Debbané, 2017; 
Lenzenweger, 2010; Meehl, 1962). They are seen as anomalies or deficits of cognitive 
(e.g., paranoid ideation, ideas of reference), social/emotional (e.g., anhedonia, lack of close 
friends), and behavioural systems (e.g., odd behaviour and language) (Cohen et al., 2015). In 
many respects, schizotypal traits resemble the clinical symptoms of schizophrenia, albeit without 
exceeding the clinical thresholds required for diagnosis with a mental disorder (Kwapil et al., 
2017; Linscott and van Os, 2013). These set of traits cluster in a manner that is similar to the 
positive, negative, and disorganization symptom clusters observed in patients with schizophrenia 
(Liddle, 1987). Likewise, they are associated with the demographic, environmental, and genetic 
risk factors that predict psychotic disorder (Linscott and van Os, 2013; Morton et al., 2017). 
Schizotypal traits predict the onset of psychotic disorders (Debbané et al., 2015; Flückiger et al., 
2016; Salokangas et al., 2013; Shah et al., 2012) as well as increased risk for non-psychotic 
psychopathology (e.g., depression, suicide) (Fisher et al., 2013; Kelleher et al., 2014; Schimanski 
et al., 2017) and impaired neurocognition, mental health status, quality of life, and daily 
functioning (e.g., Cohen et al., 2015; Ettinger et al., 2014; Siddi et al., 2017). These findings 
converge to suggest that schizotypy may be a useful phenotype for understanding the 
pathogenesis of psychosis. 
 
Sex, age, country of origin, and ethnic or migrant status correlate with the expression of 
psychosis phenotypes at clinical and subclinical levels (i.e., psychosis symptoms, schizotypal 
traits) (Jongsma et al., 2018; Kelleher et al., 2012; Linscott and van Os, 2013; McGrath et al., 
2008; McGrath et al., 2015; Nuevo et al., 2012; Spauwen et al., 2003; van Os et al., 2000). In 
general, females tend to have higher scores than males on the attributes comprising the positive 
dimension (e.g., ideas of reference, unusual perceptual experiences) whereas males have higher 
scores on those components comprising the negative (e.g., anhedonia) dimension (Bora and 
Arabaci, 2009; Fonseca-Pedrero et al., 2012; Kwapil et al., 2008; Mason and Claridge, 2006; 
Miettunen and Jääskeläinen, 2010; Raine, 1992). Some have observed minor departures from 
this general pattern, such as higher levels of social anxiety, which some view as a component of 
the negative dimension, among females (Bora and Arabaci, 2009). 
 
Psychotic symptoms usually emerge during late adolescence or early adulthood, many years 
before clinical diagnosis (Fusar-Poli et al., 2014). Schizotypal traits are also more prevalent 
during childhood and adolescence than in adulthood (e.g., Fonseca-Pedrero et al., 2012). In non-
clinical adult populations, age correlates positively with negative schizotypy and negatively with 
positive schizotypy (Mason and Claridge, 2006). On subscales of the Schizotypal Personality 
Questionnaire (SPQ) (Raine, 1991), Bora and Arabaci (2009) found that younger participants 
reported more self-reference ideas, odd beliefs, unusual perceptual experiences, odd behavior, 
and odd speech. 
 
Rates of subclinical psychosis vary across cultures, countries, and ethnic groups (Larøi et al., 
2014; McGrath et al., 2008, McGrath et al., 2015; Myers, 2011; Nuevo et al., 2012). For 
example, the prevalence of experiencing at least one psychotic symptom varies from 0.8% to 
31.4% across world regions (Nuevo et al., 2012). Among residents of defined geographic 
regions, country of origin can predict variation in rates of hallucination experiences (Johns et al., 
2002). Similar differences across countries and ethnic groups are evident for schizotypal traits. 
Scores on measures of schizotypal dimensions vary among European countries (Fonseca-Pedrero 
et al., 2015; Ortuño-Sierra et al., 2013), between American and Spanish samples (Fonseca-
Pedrero et al., 2017a; Kwapil et al., 2012), and within multiethnic populations (Cicero, 2016; 
Chmielewski et al., 1995; Kwapil et al., 2008). These differences have been obtained using 
diverse measures of schizotypal traits including the SPQ, the Chapman scales (Chmielewski et 
al., 1995), and the Oxford-Liverpool Inventory of Feelings and Experiences (O-LIFE) short-form 
(Fonseca-Pedrero et al., 2015). Significant cross-national variation is also evident in the 
incidence of psychotic disorder (Jongsma et al., 2018). 
 
To date, little research has examined epidemiologic landscape of schizotypal traits at the cross-
national level. There have been many investigations of the associations of sex, age, nationality, 
and ethnicity with schizotypal traits, in most studies comparisons have been restricted to Western 
countries or small numbers of countries. Given these limitations, our aim was to compare a broad 
array of schizotypal traits assessed with the SPQ from participants recruited in 12 Western and 
non-Western countries. We sought to better understand international variation in the self-report 
of schizotypal traits. We hypothesized that: (a) males would report more interpersonal (negative) 
and disorganized traits than females and that females would report more positive schizotypal 
traits than males; (b) younger participants would have higher scores than older participants in 
positive schizotypal traits; and (c) expression of schizotypal traits would vary across countries. 
 
2. Method 
 
This is one of a series of studies by members of the International Consortium for Schizotypy 
Research (ICSR) (https://srconsortium.org/). Other findings from the sample described here are 
reported by Fonseca-Pedrero et al., 2017b, Fonseca-Pedrero et al., 2018. 
 
Table 1. Demographic characteristics of the sample.  
Country Sex Age 
n % Male Female M SD Range 
US 10,477 38.8 3162 7212 21.9 6.7 17–55 
Spain 1123 4.2 224 899 20.2 2.0 18–29 
New Zealand 1698 6.3 515 1183 20.1 3.0 17–51 
Italy 649 2.4 305 344 24.3 3.5 19–38 
Australia 1931 7.2 634 1294 28.5 11.2 17–55 
Belgium 893 3.3 245 648 24.9 9.1 17–55 
UK 774 2.9 291 483 21.6 4.4 17–49 
Tunisia 458 1.7 137 321 20.4 1.4 18–29 
China 4907 18.2 2973 1533 19.7 1.0 17–24 
Canada 1849 6.8 562 1287 20.8 2.9 18–53 
Greece 1041 3.9 390 651 32.4 9.9 17–55 
Mauritius 1201 4.4 688 513 23.4 1.2 21–27 
Total 27,001 100 10,126 16,368 22.6 7.1 16–68 
 
2.1. Participants 
 
Participants were recruited at 21 sites across 12 countries (United States of America, United 
Kingdom, China, Belgium, Spain, Italy, Tunisia, Australia, New Zealand, Canada, Mauritius, 
and Greece). The overall sample consisted of 27,001 participants. The mean age was 22.12 years 
(SD = 6.28; range 16–55 years). Participants were divided among three age groups: 17–19 year-
olds (n = 9333; 34.6%), 20–25 year-olds (n = 10,395; 38.5%), and 26–55 year-olds (n = 3160; 
11.7%); 15.2% (n = 4113) of participants did not provide their ages. Participants included 10,126 
males (38.2%) and 16,368 females (61.8%); sex was not reported by 507 participants 
(n = 26,494). In this study we examined data at the country level, aggregating across research 
sites within each country. Table 1 shows socio-demographic characteristics of the whole sample 
by country. Information about the age, sex, and other characteristics of the samples from each 
site can be found in the supplementary material. 
 
2.2. Instrument 
 
The Schizotypal Personality Questionnaire (SPQ) (Raine, 1991) was used across all sites as a 
common index of schizotypal traits. The SPQ is 74-item self-report measure of positive, 
negative, and disorganized schizotypal traits. The SPQ yields nine subscale scores: Magical 
Thinking (Odd Beliefs), Unusual Perceptual Experiences, Ideas of Reference, Paranoid 
Ideation (Suspiciousness), Excessive Social Anxiety, No Close Friends, Constricted Affect, Odd 
Behaviour, and Odd Speech. Respondents rate each item using a dichotomous response (yes, no) 
and each subscale contains seven to nine items. Affirmative answers (item endorsements) are 
summed to compute subscale scores and an SPQ total score can be obtained as the total number 
of items endorsed. 
 
In the present work we used SPQ versions adapted, translated, and validated for each country or 
language represented: English (Raine, 1991), Spanish (Fonseca-Pedrero et al., 2014), Italian 
(Fossati et al., 2003), Chinese (Chen et al., 1997), Arabic (Lahmar et al., 2014), French (Dumas 
et al., 2000), Creole (Reynolds et al., 2000), and Greek (Tsaousis et al., 2015). 
 
Raine (1991) based the SPQ on the nine traits contained in the DSM-III-R definition of 
schizotypal personality disorder (American Psychiatric Association, 1987). Confirmatory factor 
analyses have demonstrated that the positive-negative-disorganized factor model provides a good 
fit to SPQ data (Fonseca-Pedrero et al., 2018). The positive (cognitive-perceptual) dimension 
comprises the Odd Beliefs, Unusual Perceptual Experiences, Ideas of Reference, 
and Suspiciousness subscales. The interpersonal (negative) dimension comprises the Excessive 
Social Anxiety, No Close Friends, Suspiciousness, and Constricted Affect subscales. The 
disorganized dimension comprises the Odd Behaviour and Odd Speech subscales. 
 
2.3. Procedure 
 
Conventions for obtaining informed consent required by each investigator's research institution 
and IRB or ethical committees were followed. All participants provided written informed 
consent prior to participation. The study was conducted in accordance with the guidelines of the 
Declaration of Helsinki (World Medical Association, 2013). 
 
2.4. Data analyses 
 
Descriptive statistics for the nine SPQ subscales, the three schizotypal dimensions and SPQ total 
score were calculated, both overall and for the sample as broken down by sex, age, and country. 
Subsequently, country differences in SPQ scores were tested using analyses of variance 
(ANOVA): univariate ANOVA of the SPQ total and multivariate ANOVA (MANOVA) of the 
three SPQ dimension scores. (MANOVA was also applied to the nine SPQ subscale scores, with 
results from these analyses reported in the supplementary online material.) ANOVA 
and MANOVA included sex, age, and country as fixed factors. Partial eta squared (ηp2) was 
employed as an effect-size estimate. 
 
Participants with missing data for more than two SPQ items were excluded from the analyses. 
Where data were missing for one or two items, those data were imputed with regression-based 
estimates, to which an error component was added, using the SPSS Missing Value Analysis 
module. Following exclusion for missing data, the analysis sample consisted of 22,864 
participants (n = 9132 males; n = 9319 aged 16–19 years, n = 10,387 aged 20–25 years, 
and n = 3158 aged 26–55 years). By country, the sample distribution was: USA = 8145, 
Spain = 1123, New Zealand = 1698, Italy = 649, Australia = 778, Belgium = 893, UK = 774, 
Tunisia = 458, China = 4257, Canada = 1849, Greece = 1040, and Mauritius = 1200. SPSS 22.0 
(IBM Corp Released, 2013) was used for data analyses. 
 
3. Results 
 
3.1. Sex-related manifestation of schizotypal traits 
 
There was no effect of sex on the SPQ total (F(1,22,796) = 1.22, p = 0.27, ηp2 < 0.001). In contrast, 
sex affected schizotypal dimensions (λ = 0.998, F(3,22,794) = 15.31, p < 0.001, ηp2 = 0.002) with 
differences between males and females for the positive and disorganization schizotypal 
dimensions, but not the interpersonal dimension (Table 2). Table 3 gives means and standard 
errors for SPQ dimensions for males and females. Females scored higher than males on the 
positive schizotypal dimensions; males scored higher than females on the disorganization 
dimension. 
 
Table 2. P values and effect sizes by country, sex, and age for each schizotypal dimension. 
Effect Positive Negative Disorganized 
p ηp2 p ηp2 p ηp2 
Country <0.01 0.013 <0.01 0.041 <0.01 0.013 
Sex <0.01 0.001 0.35 
 
0.01 
 
Age <0.01 
 
0.69 
 
0.07 
 
Country × Sex <0.01 0.002 0.01 0.001 0.01 0.001 
Country × Age <0.01 0.004 <0.01 0.004 <0.01 0.004 
Age × Sex 0.12 
 
0.05 
 
0.20 
 
Country × Age × Sex 0.08 0.001 0.89 0.001 0.84 0.001 
 
Table 3. Estimated means scores and standard errors for the SPQ total score and schizotypal 
dimensions according to sex and age. 
Schizotypal Sex Age 
Male Female 16–19 years-old 20–25 years-old 26–55 years-old 
M SE M SE M SE M SE M SE 
Positive 8.60 0.17 9.59 0.20 9.56 0.17 9.23 0.09 8.49 0.37 
Interpersonal 9.60 0.19 9.88 0.22 9.63 0.18 9.80 0.09 9.78 0.39 
Disorganization 5.27 0.11 4.84 0.13 5.31 0.10 5.04 0.05 4.82 0.23 
Total score 21.07 0.35 21.69 0.42 22.00 0.34 21.52 0.17 20.62 0.75 
Note. M = Mean; SE = Standard error. 
 
3.2. Age-related variability in schizotypal traits 
 
There was no evidence that age group affected the SPQ total score 
(F(2,22,796) = 2.90, p = 0.055, ηp2 < 0.001) whereas age differences were evident on the three 
schizotypal dimensions (λ = 0.999, F(6,45,588) = 2.35, p = 0.029, ηp2 < 0.001; Table 2 shows p-
values and effect sizes for each dimension). The significant age effects reflected a tendency for 
adolescents to report more schizotypal traits than older participants (Table 3). However, this 
main effect was qualified by an interaction between age and dimension such that the youngest 
group scored significantly higher than the other age groups in the positive schizotypal dimension. 
In contrast, no statistically significant differences among age groups emerged for the 
interpersonal and disorganization dimensions. 
 
3.3. Country-related variability in schizotypal traits 
 
SPQ total scores differed significantly across countries 
(F(11,22,796) = 26.56, p < 0.001, ηp2 = 0.013). Fig. 1 gives estimated mean total SPQ scores for 
each country. Participants from Tunisia and the UK obtained the highest SPQ total scores; 
participants from Italy obtained lower scores than participants from other regions. 
 
 
Fig. 1. Estimated means (standard errors) of SPQ total score across countries. 
 
The MANOVA of schizotypal dimensions also showed differences across countries (λ = 0.904, 
F(33,67,156) = 70.57, p < 0.001, ηp2 = 0.033; Table 2 for p values and effect sizes). Mean scores on 
the positive schizotypal dimension, were highest for participants from Tunisia, and lowest for 
those from Canada and Italy (Table 4). Tunisian participants also scored highest on average on 
the interpersonal schizotypal dimension; mean scores were lowest for participants from China 
and Australia. On the disorganization schizotypal dimension, scores were highest for participants 
from the UK and lowest for those from Italy and Spain. 
 
3.4. Interactions among country, sex, and age as predictors of schizotypal traits 
 
For SPQ total score, the Country × Sex interaction was not significant (F(11,22,796) = 2.07, 
p < 0.05, ηp2 = 0.001) but the Country × Age interaction was (F(20,22,796) = 4.29, 
p < 0.001, ηp2 = 0.004). Results were not significant, however, for interactions between 
Sex × Age (F(2, 22,796) = 2.66, p = 0.070, ηp2 = 0.001) and Country × Sex × Age (F(20, 22,796) = 0.76, 
p = 0.776, ηp2 = 0.001). Closer examination of the Country × Sex interaction revealed that scores 
were higher for females than males in several countries, including Italy, Tunisia, and Australia 
(Table 5). Associations with age also varied by country such that in some countries, such as the 
US, members of the youngest group scored higher than those in the other age groups. In other 
countries, such as Tunisia, in contrast, the older age group scored higher than youngest group. 
 
Table 4. Schizotypal dimension scores by country. 
Country Positive Negative Disorganized 
M SE M SE M SE 
US 8.58 0.08 10.56 0.09 5.22 0.05 
Spain 7.79 0.39 9.33 0.42 3.97 0.24 
New Zealand 7.91 0.32 8.40 0.34 4.57 0.20 
Italy 6.95 0.43 7.57 0.46 3.79 0.27 
Australia 8.19 0.25 7.44 0.27 5.17 0.15 
Belgium 8.39 0.25 10.30 0.26 5.34 0.15 
UK 10.48 0.27 11.37 0.29 7.13 0.17 
Tunisia 13.72 1.20 13.75 1.29 6.94 0.74 
China 10.44 0.10 7.05 0.11 4.87 0.06 
Canada 7.19 0.25 8.94 0.27 4.78 0.16 
Greece 9.52 0.31 9.55 0.33 4.11 0.19 
Mauritius 11.14 0.34 12.71 0.36 4.57 0.21 
Grand mean 9.17 0.13 9.74 0.14 5.06 0.08 
Note. M = Mean; SE = Standard error. 
 
Table 5. Estimated means scores and standard errors for the total score of SPQ according to 
country, sex, and age. 
Country Sex Age groups 
Male Female 16–19 years-old 20–25 years-old 26–55 years-old 
M SE M SE M SE M SE M SE 
US 22.62 0.26 21.33 0.19 22.43 0.21 23.08 0.26 20.41 0.36 
Spain 18.91 1.33 19.13 0.86 20.57 0.67 20.67 0.68 15.83 2.17 
New Zealand 18.58 1.07 19.21 0.72 18.37 0.46 19.28 0.49 19.05 1.82 
Italy 14.80 1.35 17.23 1.13 15.79 2.41 16.87 0.61 15.39 0.89 
Australia 17.53 0.82 20.34 0.59 21.81 1.13 20.75 0.72 14.24 0.71 
Belgium 21.70 0.86 21.31 0.50 25.44 1.03 20.07 0.70 18.99 0.84 
UK 26.35 0.86 26.22 0.66 28.42 0.80 24.58 0.64 25.85 1.27 
Tunisia 27.81 2.56 32.71 4.19 24.70 1.38 28.40 0.73 37.67 7.19 
China 21.08 0.23 21.25 0.35 21.31 0.32 21.03 0.26 – – 
Canada 19.59 0.86 18.17 0.57 20.25 0.55 19.57 0.40 16.83 1.39 
Greece 20.14 1.08 20.16 0.61 22.89 1.55 19.59 0.93 17.96 0.47 
Mauritius 25.08 1.03 23.81 0.90 – – 24.32 0.38 24.57 1.31 
Note. M = Mean; SE = Standard error; In Mauritius and China there are two age-groups without participants. 
 
MANOVA indicated interactions between Country × Sex (λ = 0.995, F(33,67,156) = 3.54, 
p < 0.001, ηp2 = 0.002), Country × Age (λ = 0.990, F(60,68,005) = 3.91, p < 0.001, ηp2 = 0.003) 
significantly predicted SPQ scores for the three schizotypal dimensions (Table 2). Results were 
not significant for interactions between Sex and Age (λ = 0.999, F(6, 45,588) = 1.96, 
p = 0.067, ηp2 = 0.000) and for Country × Sex × Age (λ = 0.997, F(60, 68,005) = 1.22, 
p = 0.122, ηp2 = 0.001). 
 
Decomposition of the significant interactions yielded evidence of a complex pattern of 
associations (see Supplementary materials for complete results). For instance, females from most 
countries scored higher than males on the positive schizotypal dimension; however, males from 
Mauritius scored higher than women and no significant sex differences were evident for 
participants from the US, Canada, and Greece. For the interpersonal schizotypal dimension, 
mean scores were similar across sex for most countries; however, female participants from 
Spain, Italy, and Tunisia, scored higher than males. Men from all countries except Australia 
obtained higher scores than women on the disorganized schizotypal dimension. 
 
4. Discussion 
 
To improve understanding of both the phenotypic expression of schizotypal traits and the various 
manifestations of psychosis liability (Cohen and Fonseca-Pedrero, 2017), we set out to examine 
differences according to sex, age, and nationality in the expression of schizotypal traits using a 
large sample of participants recruited from 12 countries (n = 27,001). To our knowledge, this is 
the largest comprehensive study of schizotypal traits in a non-clinical sample published to date. 
This collaborative effort, in which multiple research groups have shared data, has provided an 
unprecedented opportunity to explore the epidemiologic landscape of schizotypal traits with a 
single instrument—the SPQ. 
 
The results have demonstrated that schizotypal traits varied according to sex, age, and country. 
Females scored higher than males in the positive dimension, whereas males scored higher in 
the disorganization dimension. By age, a significant decrease in the positive schizotypal traits 
was observed. Epidemiological expression of schizotypal traits varied by country. Moreover, 
several interactions by sex, age, and country were found. If schizotypal traits reflect liability 
for schizophrenia-spectrum disorders, schizotypy and psychosis should be associated with the 
same variables. In this study, sex, age, and country were differentially associated with 
schizotypal traits in ways that approximately mirror associations with diagnosed psychotic 
disorders and subclinical psychotic experiences (e.g., schizotypal traits and psychotic-like 
experiences) (Jongsma et al., 2018; Kelleher et al., 2012; Linscott and van Os, 2013; McGrath et 
al., 2008; McGrath et al., 2015; Nuevo et al., 2012; Spauwen et al., 2003; van Os et al., 2000). 
 
As hypothesized, the manifestation of schizotypal traits varied across nations; however, means 
schizotypal scores were similar across countries. Compared to those from other countries, 
Tunisian participants had higher scores on almost all schizotypal dimensions. In particular, 
Tunisian and UK samples obtained the highest total scores on the SPQ and Italy the lowest. The 
Chinese sample had a distinct pattern of ratings, with magical ideation and lower indices of 
interpersonal schizotypal traits. In addition, the pattern of results found is clearly modulated not 
only by country but as by its interactions with sex and age. To date, most of the cross-national 
research of schizotypy involved comparison between two or four countries (Fonseca-Pedrero et 
al., 2015, Fonseca-Pedrero et al., 2017a; Sierro et al., 2016; Kwapil et al., 2012; Ortuño-Sierra et 
al., 2013), thus it is quite difficult to compare these results with previous research. For 
instance, Fonseca-Pedrero et al. (2015) using the s-OLIFE across four European countries (UK, 
Switzerland, Italy, and Spain), found differences when the mean scores were compared. The 
Spanish sample, compared to other countries, showed the lowest score on unusual 
experiences, anhedonia, and impulsive nonconformity dimensions. In another study Fonseca-
Pedrero et al. (2017a), found that he American group scored higher than the Spanish group in all 
schizotypal traits, except Ideas of Reference and Suspiciousness. These findings, therefore, are 
convergent with those from previous studies measuring psychotic symptoms and subclinical 
psychotic symptoms and experiences (Jongsma et al., 2018; Larøi et al., 2014; McGrath et al., 
2008, McGrath et al., 2015; Myers, 2011; Nuevo et al., 2012). 
 
In the present study, we did not have a priori hypotheses on how schizotypy would differ across 
participating countries. We assume that differences across countries would reflect a range of 
factors. These included methodological variability, such as the use of different strategies for 
ascertaining and recruiting participants. It must be added that the exclusive use of the SPQ to 
measure schizotypal traits, while advantageous in that it provided consistency across the 
compiled datasets with regard to the domains surveyed, may also have functioned in distinctive 
ways in different countries. The SPQ in particular was developed in North America and has been 
most widely used in that context. The instrument may thus reflect idiosyncrasies of that society 
that do not translate easily to other cultural contexts. One question that inevitably arises is 
whether the observed differences according to country, sex, and age are substantively 
informative about schizotypy or whether they simply reflect systematic measurement error 
embedded within the instrument used to collect the data. In this framework, the effect sizes 
found are relevant and should be considered carefully, particularly given that nationality 
contributes much more variance to SPQ scores than age or sex. It must be noted that the sex and 
age effects are mostly trivial, contributing to very little variance in ratings. Similarly, the country 
x sex and country x age effects are small contributors to observed variance. 
 
Our data do not provide answers to this question, but we urge future researchers to consider it 
seriously. Cultures may also vary in the degree to which accept particular symptoms 
(e.g., hallucinations and magical thinking) as normative experiences. For instance, some 
experiences that members of individualistic cultures identify as anomalous or unusual may be 
more readily tolerated by members of communal cultures. Future studies would benefit from 
taking an “anthropological” or proper cross-cultural approach that would allow researchers to 
explore these possibilities in depth and to both generate and test specific hypotheses. By 
assessing schizotypal traits in individuals who represent different cultures, we have the potential 
to gain important knowledge about cultural differences in social and affective functioning 
(Cohen et al., 2015) and to clarify how these cognitive, emotional, and motivational traits relate 
to important variations in human behavior (Henrich et al., 2010). 
 
With regard to sex, females in our study scored higher than males on subscales within the 
positive schizotypal dimension, whereas males scored higher on subscales within the 
disorganization dimension. Scores did not differ significantly between males and females on 
subscales within the interpersonal schizotypal dimension. The observed differences between 
males and females were partially concordant with the results of studies that used other 
schizotypal/schizotypy scales. For instance, previous research has similarly demonstrated that 
males show more disorganized traits than females (Bora and Arabaci, 2009; Mason and Claridge, 
2006), whereas females report more positive schizotypal (i.e., odd beliefs) traits than males 
(Bora and Arabaci, 2009; Fonseca-Pedrero et al., 2012; Kwapil et al., 2008; Raine, 1992). The 
literature is mixed with regard to sex differences on measures that tap the interpersonal 
schizotypal dimension; whereas some have found no significant sex differences (Bora and 
Arabaci, 2009), others found evidence that males and females differ on this dimension (Fonseca-
Pedrero et al., 2012; Kwapil et al., 2008; Mason and Claridge, 2006; Miettunen and Jääskeläinen, 
2010; Raine, 1992). 
 
With strong consistency across countries, adolescents scored higher than participants from other 
age groups on subscales within the positive schizotypal dimension. This finding is in line with 
previous research, which has demonstrated that adolescents tend to score higher than adults 
(university students or general population) on measures of most schizotypal dimensions 
(Badcock and Dragovic, 2006; Bora and Arabaci, 2009; Chen et al., 1997; Fonseca-Pedrero et 
al., 2012; Fossati et al., 2003), particularly the positive dimension (Mason and Claridge, 2006). 
For instance, Bora and Arabaci (2009) found that younger participants scored significantly 
higher than older ones on subscales measuring ideas of reference, odd beliefs, unusual perceptual 
experiences, odd behavior and odd speech. Moreover, the results confirmed previous findings 
from meta-analyses and cross-national studies that other subclinical expressions of the psychosis 
phenotype (e.g., psychotic-like experiences) are negatively associated with age (Linscott and van 
Os, 2013; McGrath et al., 2015). 
 
The current findings raise a potentially important clinical question regarding whether cultural 
differences in schizotypy are genuine differences that may stem from culture-specific 
environmental stressors, or whether they instead emerge as a function of a relative lack of 
cultural sensitivity in the application of DSM diagnostic criteria across cultures (Raine, 2006). 
This issue is particularly pertinent to the present study, as the SPQ was developed based 
on DSM criteria. Future research using this measure would benefit from careful consideration of 
the relevance of DSM criteria in the cultural context under study. Moreover, our cross-cultural 
findings could be of crucial relevance for research on psychosis and its early detection and 
prevention. For instance, they could be of value for determining cut-off points for detecting 
participants at risk for psychosis in the context of a given culture as well as age and gender. A 
practical implication is that studies comparing “high vs low schizotypy groups” need to use age 
and sex referenced norms that are also suitable to the specific culture from which participants are 
drawn. The results are also important clinically, in that they suggest that schizotypy must be 
considered as a valid construct around the world, and not just in Western culture. However, they 
also suggest that generalizations should be made only cautiously, given the interactions that we 
observed among sex, age, and country. These interactions, which raise the possibility of subtle 
individual variability in the manifestation of schizotypy, might be fruitfully explored in clinical 
settings using qualitative approaches or by examining associations between schizotypal 
phenotypes and genetic variants that are distributed unevenly across cultures. Finally, these data 
may allow us to further understand protective and risk factors for psychosis spectrum disorders at 
a cross-national level (Cohen et al., 2015). 
 
The results of the present work should be considered in the light of several limitations. First, 
there is an inherent problem in the use of self-report as an indicator of schizotypal traits. 
However, despite their limitations, self-report instruments are brief, inexpensive, non-invasive, 
and user-friendly, and thus amenable to use in clinical research or community settings in which 
large samples may be screened. Also, the validity and clinical relevance of psychometric high-
risk methodology has been documented and research has found this approach to yield concordant 
results with research on individuals with schizophrenic symptomatology (Cochrane et al., 2010) 
and with conventional interview-based high-risk approaches for studying psychosis (Barrantes-
Vidal et al., 2013). Second, the nature of the sample, which was composed mostly of college 
students, may limit generalization of the results to other populations of interest. Samples from 
the general population may differ from college and adolescent samples in that age, sex, and other 
demographic variables may carry artificially increased weight. In fact, most of the subsamples 
used in this study are WEIRD (Western, Educated, Industrialized, Rich, and Democratic) 
individuals and are probably unrepresentative of the world's population (Henrich et al., 2010). 
Third, the fact that not all the samples used the SPQ infrequency response to detect those 
participants who displayed random or pseudo-random patterns of responses undermines the 
validity and generalizability of the results found in the present cross-national study. Finally, we 
do not have clinical information about any mental disorders present in the sample. 
 
5. Conclusions 
 
We have provided a comprehensive description of schizotypal traits using a large and 
multinational sample, with participants drawn from 12 countries. The present work aimed to 
improve understanding about the epidemiological distribution of schizotypal traits across nations 
at the population level. The findings indicate that schizotypal traits vary across country, sex, and 
age, and are associated with similar demographic factors to those found in patients with 
psychosis. In summary, these results provide more fine-grained analyses of phenotypic 
expressions of schizotypal traits to guide the field. 
 
Future studies should focus on the manifestation of these traits across multiple levels of analyses, 
multiple indicators (e.g., genes, molecules, cells, circuits, physiology, behaviors, and self-report 
levels) and new procedures of assessment (e.g., experience sampling method). Furthermore, it is 
relevant to add new measurement models and theories (e.g., network analyses, chaos theory) to 
provide new insights in this arena (Borsboom, 2017; Fonseca-Pedrero, 2017; Nelson et al., 
2017). The study of schizotypal traits is a field that is in clear expansion and several extremely 
interesting questions remain unresolved. 
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